Skip to main content
. 2020 Dec 1;27(6):e569–e577. doi: 10.3747/co.27.5995

TABLE I.

Detection rates for individual alterations and biomarkers in conventional tests compared with Foundation Medicine Incorporated (FMI) tests

Gene or biomarker Detection rate (%) by test type
Conventional FMI
ALK18,19 2.1 2.9
PD-L1a,20 30.2
EGFR7,21,22 11.9 14.0
KRAS7,22 17.5 22.4
BRAF7,22,23 1.4 4.0
ROS17,22 0.7 1.0
ERBB27,22 2.1 4.2
MET7,22 2.6 5.8
RET7,22 0.7 1.7
a

Tested using immunohistochemical assays and used in conjunction with FoundationOne testing.